What is DCA?

DCA is the short form of DeoxyCholic Acid, and belongs to the group of secondary bile acids which are transported in our enterohepatic circulation. We know about the existence of DCA for about the last 100 years, but the mainstream of conservative medicine has not understood the role of deoxycholic acid yet - apart of its property in fat digestion and some other minor facts. According to the state of the science DCA is a harmless, but also a useless natural substance to be soon wiped out by evolution.

But in truth deoxycholic acid is a main immunity stimulator in our body

Our “Immunity Vitamin”.


--------------------------------------------------------------------------------

How does DCA work?

Deoxycholic acid is produced by special bacteria of the intestinal flora. Naturopaths realized the obvious correlation of a healthy intestinal flora and a strong immunity, but without having a sufficient theoretical explanation for this fact. Indeed they have very good healing results by restoring the intestinal flora, and so indirectly reparing the DCA-dependent part of the immune system.

After being produced in the gut, deoxycholic acid spreads out all over the body, and can be found in all our tissues. It patrols throughout the whole body as a kind of a “health cop”.

If DCA stumbles across a local inflammation or a cancer cells (specifications),
it activates immeditaly a strong local immune response.

The part of the immune system that is immensly boosted by DCA is the so called unspecific immune system, and it is based on the macrophages. DCA influences our hormonal system as well. As an "immunity hormone" it helps the body to geht into a condition where recovery is easy.

This way a starting disease is fought back in the very beginning of the battle. DCA works very quickly and effective. An example: Indicated fresh inflammations (as herpes or many urinological diseases) heal in big parts or totally in two to three days – in total harmony with the needs of the body.


--------------------------------------------------------------------------------

Which diseases can be healed with DCA?

Deoxycholic acid is not a magic potion. The special thing about DCA in medical therapy is the fact that many of the illnesses responding to the immunity vitamin can be found among the so called civilizational diseases or diseases where a proper medicament hasn´t been developped yet. If we take a loo around the diseases responding very well to a DCA treatment, we find in first place:

Virus infections as herpes, chickenpox or enzephalitis as well as
Bacteria induced inflammations like of the middle ear, the kidneys or the urinary tract
and many neuralgia.

In several cases some manifestations of cancer were healed with deoxycholic acid.


--------------------------------------------------------------------------------
For more information see www.dcaimmunityvitamin.com ITS THE GUT, the bile, of course!!!!!!!!!!!!!

Blissed be, Annie

Small Molecule Offers Big Hope Against Cancer
Science Daily — DCA is an odourless, colourless, inexpensive, relatively non-toxic, small molecule. And researchers at the University of Alberta believe it may soon be used as an effective treatment for many forms of cancer.


U of A researcher Dr. Evangelos Michelakis has shown that this tiny DCA molecule could make a difference in the battle against cancer.

Dr. Evangelos Michelakis, a professor at the U of A Department of Medicine, has shown that dichloroacetate (DCA) causes regression in several cancers, including lung, breast, and brain tumors.

Michelakis and his colleagues, including post-doctoral fellow Dr. Sebastian Bonnet, have published the results of their research in the journal Cancer Cell.

Scientists and doctors have used DCA for decades to treat children with inborn errors of metabolism due to mitochondrial diseases. Mitochondria, the energy producing units in cells, have been connected with cancer since the 1930s, when researchers first noticed that these organelles dysfunction when cancer is present.

Until recently, researchers believed that cancer-affected mitochondria are permanently damaged and that this damage is the result, not the cause, of the cancer. But Michelakis questioned this belief and began testing DCA, which activates a critical mitochondrial enzyme, as a way to "revive" cancer-affected mitochondria.

The results astounded him.

Michelakis and his colleagues found that DCA normalized the mitochondrial function in many cancers, showing that their function was actively suppressed by the cancer but was not permanently damaged by it.

More importantly, they found that the normalization of mitochondrial function resulted in a significant decrease in tumor growth both in test tubes and in animal models. Also, they noted that DCA, unlike most currently used chemotherapies, did not have any effects on normal, non-cancerous tissues.

"I think DCA can be selective for cancer because it attacks a fundamental process in cancer development that is unique to cancer cells," Michelakis said. "Cancer cells actively suppress their mitochondria, which alters their metabolism, and this appears to offer cancer cells a significant advantage in growth compared to normal cells, as well as protection from many standard chemotherapies. Because mitochondria regulate cell death--or apoptosis--cancer cells can thus achieve resistance to apoptosis, and this appears to be reversed by DCA."

"One of the really exciting things about this compound is that it might be able to treat many different forms of cancer, because all forms of cancer suppress mitochondrial function; in fact, this is why most cancers can be detected by tests like PET (positron emission tomography), which detects the unique metabolic profile of cancer compared to normal cells," added Michelakis, the Canada Research Chair in Pulmonary Hypertension.

Another encouraging thing about DCA is that, being so small, it is easily absorbed in the body, and, after oral intake, it can reach areas in the body that other drugs cannot, making it possible to treat brain cancers, for example.

Also, because DCA has been used in both healthy people and sick patients with mitochondrial diseases, researchers already know that it is a relatively non-toxic molecule that can be immediately tested in patients with cancer.

Furthermore, the DCA compound is not patented and not owned by any pharmaceutical company, and, therefore, would likely be an inexpensive drug to administer, Michelakis added.

However, as DCA is not patented, Michelakis is concerned that it may be difficult to find funding from private investors to test DCA in clinical trials. He is grateful for the support he has already received from publicly funded agencies, such as the Canadian Institutes for Health Research (CIHR), and he is hopeful such support will continue and allow him to conduct clinical trials of DCA on cancer patients.

"This preliminary research is encouraging and offers hope to thousands of Canadians and all those around the world who are afflicted by cancer, as it accelerates our understanding of and action around targeted cancer treatments," said Dr. Philip Branton, Scientic Director of the CIHR Institute of Cancer.

Michelakis's research is currently funded by the CIHR, the Canada Foundation for Innovation, the Canada Research Chairs program, and the Alberta Heritage Foundation for Medical Research.

Note: This story has been adapted from a news release issued by University of Alberta.

Blissed be, Annie